Karima Benbouazza

University Mohammed V Agdal, Rabat, Rabat-Salé-Zemmour-Zaër, Morocco

Are you Karima Benbouazza?

Claim your profile

Publications (83)93.7 Total impact

  • Source

    Full-text · Article · Jan 2014 · Annals of the Rheumatic Diseases
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A 70-year-old woman with a history of medial femoro-tibial compartment of knee osteoarthritis was admitted for acute arthritis six days after a second intra-articular injection of Hyaluronic acid. The joint fluid was inflammatory, with no crystals, and laboratory tests showed marked inflammation leading to antibiotic treatment for suspected septic arthritis. The persistent symptoms and negative results of joint fluid and blood cultures led to discontinuation of the antibiotic therapy after 10 days. Anti-inflammatory with rehabilitation therapy of the knee relieved the symptoms, and the patient was discharged home 3 weeks after her admission. Aseptic arthritis induced by repeated Hyaluronic acid injection is the most likely diagnosis. Physicians should be conscious of this extremely severe complication.
    Full-text · Article · Jun 2012 · Pan African Medical Journal
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVES: In Morocco, the patients affected by ankylosing spondylitis (AS) presents a high frequency of coxitis. Our study reports, for the first time, the polymorphism of Human Leukocyte Antigen (HLA) class I and class II molecules in the Moroccan patients. METHODS: Forty-six patients diagnosed with an AS and coxitis were compared to a group of 183 healthy controls matched by age, sex and ethnic origin. The HLA typing was performed using microlymphocytotoxicity for the class I (-A, -B) and PCR-SSP for the class II (-DR, -DQ). RESULTS: We found a significant increase of the HLA-B27 antigen frequency (P<0.0001, RR=20.9) in AS patients (29.3%) compared to the controls (3.2%) and a significant decrease in the frequency of HLA-B12 and HLA-B18 antigens. Examination of HLA class II distribution shows a significant increase of the HLA-DRB1*11 allele frequency in patients (P<0.0001). Concerning HLA-DQB1* alleles, no significant difference between patients and controls was appreciable. CONCLUSIONS: The HLA-B27 antigen is involved in the predisposition to the AS with coxitis in the Moroccan population. However, the low frequency observed in our population suggests the existence of other genetic and/or environmental factors. Other HLA genes seem to confer a predisposing effect (DRB*11) or a protective effect (B12 and B18) against the disease.
    Full-text · Article · Feb 2012 · Pathologie Biologie
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: L’objectif de cette étude était d’évaluer la rémission chez les patients avec polyarthrite rhumatoïde (PR) précoce traités par des médicaments antirhumatismaux modifiant l’évolution de la maladie (DMARDs) conventionnels et d’identifier des facteurs prédictifs possibles de rémission.
    Full-text · Article · Dec 2011 · Revue du Rhumatisme
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study aimed to establish the profile and the evolution of an early Rheumatoid arthritis (RA) cohort in the Moroccan population and also to search possible predictor factors of structural progression. Patients with early RA (< 12 months) were enrolled in a 2-year follow-up study. Clinical, biological, immunogenetic, and radiographical data were analyzed at study entry and at 24 months. Presence of radiographic progression was retained when the total score was superior to the smallest detectable difference (SDD) calculated to be 5.4 according the Sharp/van der Heijde (SVDH) method. Fifty one patients (88.8% women, mean age of 46.9 [ 24-72 ] ± 10.8 years, mean disease duration of 24 [ 6-48 ] ± 13.9 weeks) were enrolled in this study. 68.6% were illiterate and 19.6% reported at least one comorbid condition. The mean delay in referral for specialist care was 140 [ 7-420 ] ± 43 days.Thirteen patients (62.5%) were IgM or IgA RF positive. HLA-DRB1*01 and DRB1*04 alleles were present respectively in 11.8% and 45.1% of patients.At baseline, 35.3% patients were taking corticosteroids and 7.8% were under conventional DMARDs.At 24 months, 77.2% received a median dose of 5 mg/day of prednisone. Methotrexate (MTX) was the most frequently prescribed DMARD, being taken by 65.2% of patients. 13.6% of patients had stopped their DMARD because of socioeconomic difficulties.Comparison of clinical and biologic parameters between baseline and 24 months thereafter revealed a significant global improvement of the disease status including morning stiffness, pain score, swollen joint count, DAS 28 and HAQ scores, ESR and CRP.Sixteen patients (34.8%) were in remission at 2 years versus no patients at baseline; P < 0.001.Forteen patients (27.5%) had at least one erosion at baseline. Radiographic progression occurred in 33.3% of patients and was associated in univariate analysis to swollen joint count (p = 0.03), total SVDH score (P = 0.04) and joint space narrowing score (P = 0.03). No independent factors of radiographic progression were shown by logistic regression. These study reports, provided for the first time in Morocco, a developing African country, a large amount of information concerning the profile and the course of early RA.Patients who were receiving, for most of them, Methotrexate in monotherapy and low doses of corticosteroids, showed an improvement of all clinic and biologic disease parameters. Moreover, DAS remission was obtained in one third of patients and two thirds of the cohort had no radiographic progression at 2 years. No predictor factors of radiographic progression were found out.These results should be confirmed or not by a large unbiased RA cohort which will give more relevant information about early RA characteristics and its course and will constitute a major keystone of its management.
    Full-text · Article · Nov 2011 · BMC Musculoskeletal Disorders
  • Source
    H Raissouni · K Benbouazza · B Amine · L Tahiri · N.H. Hassouni

    Full-text · Article · Nov 2011 · Revue Neurologique
  • Source

    Full-text · Article · Oct 2011 · Journal of ultrasound in medicine: official journal of the American Institute of Ultrasound in Medicine
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study aimed to evaluate remission in patients with early RA treated by conventional DMARDs and to identify its possible predictor factors. Patients with early RA (<12 months) were enrolled in a 2-year follow-up study. Standard evaluation completed at baseline and at 24 months included clinical, laboratory, functional and structural assessment. Clinical remission after 2 years of follow-up was defined when DAS28 was less than 2.6. Possible predictor factors for remission were analyzed. Fifty-one patients (88.2% women, mean age of 46.9 [24-72] years, mean disease duration of 24 [6-48] weeks) were enrolled in this study. The delay in referral for specialist care was 140 [7-420] days. Rheumatoid factor, anti-CCP, HLA-DRB1*01 and DRB1*04 alleles were present respectively in 62.5, 56.6, 11.8, and 45.1% of patients. At 24 months, 77.2% received a median dose of 5 (0-8) mg/day of prednisone and 65.2% was taking methotrexate (MTX). 13.6% of patients had stopped their DMARD because of socioeconomic difficulties. At 24 months, we noted a significant improvement of morning stiffness, pain score, swollen joint count, ESR, CRP, DAS28 and HAQ scores. Remission at 2 years was noted in 34.8% of patients and was significantly associated in univariate but not in multivariate analysis to male sex (P=0.02) and to short delay in referral for specialist (P=0.03). In this cohort of early RA patients treated with conventional DMARDs, especially with methotrexate in monotherapy, remission at 2-year of follow-up was obtained in one third of patients. No predictor factors of remission were found out. These results should be verified by further studies.
    Full-text · Article · Apr 2011 · Joint, bone, spine: revue du rhumatisme
  • Source

    Full-text · Article · Nov 2010

  • No preview · Article · Nov 2010

  • No preview · Article · Nov 2010

  • No preview · Article · Nov 2010
  • El Alaoui H · Benbouazza K · Hajjaj-Hassouni N

    No preview · Article · Nov 2010

  • No preview · Article · Nov 2010
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Stiff limb syndrome is a clinical feature of the stiff person syndrome, which is a rare and disabling neurologic disorder characterized by muscle rigidity and episodic spasms that involve axial and limb musculature. It is an autoimmune disorder resulting in a malfunction of aminobutyric acid mediated inhibitory networks in the central nervous system. We describe a patient diagnosed by neurological symptoms of stiff limb syndrome with a good outcome after treatment, and a review of the related literature. A 49-year-old male patient presented with a progressive stiffness and painful spasms of his both legs resulting in a difficulty of standing up and walking. The diagnosis of stiff limb syndrome was supported by the dramatically positive response to treatment using diazepam 25 mg/day and baclofen 30 mg/day. This clinical case highlights the importance of a therapeutic test to confirm the diagnosis of stiff limb syndrome especially when there is a high clinical suspicion with unremarkable electromyography.
    Full-text · Article · Feb 2010 · Cases Journal
  • Source

    Full-text · Article · May 2009 · Joint Bone Spine
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We report two cases of primary Non-Hodgkin's Lymphoma in the spine leading to radicular compression secondary to infiltration of lumbar body vertebras. The two patients were free of either nodular or other extra-nodular disease. Treatment consisted of chemotherapy alone, one patient have had a cauda equina syndrome and surgical decompression was performed in emergency. The patients were in remission for 20 months after diagnosis. A review is given for the incidence of primary vertebral localization of lymphoma, its diagnosis, treatment and prognosis.
    Full-text · Article · May 2009 · Rheumatology International
  • Source
    Amine Bouchra · Karima Benbouazza · Najia Hajjaj-Hassouni
    [Show abstract] [Hide abstract]
    ABSTRACT: We describe a 47-year-old woman with severe spondylarthropathy secondary to ulcerative colitis who developed a Guillain-Barre after the use of anti-TNF-alpha. She first developed ulcerative colitis in November 1997. In 2003, she developed uveitis and, in 2005, axial and enthesitis form of spondylarthropathy. In May 2007, her condition was exacerbated. Therapy with infliximab has been initiated. The patient received 5-mg/kg infusions of infliximab. She had significant improvement in her arthritis and was in remission for her ulcerative colitis. She was admitted to the hospital 2 weeks after her third dose of infliximab for having developed paraesthesia of her hands and lower limbs. Neurophysiology studies demonstrated an acquired segmental demyelinating polyneuropathy consistent with Guillain-Barre syndrome (GBS). Laboratory investigations were unremarkable. She was treated with intravenous corticosteroids with no improvement. After this, she received infusions of intravenous gammaglobulin (IVIg) with complete recovery of the muscle strength within a few weeks. A follow-up electromyographic study 3 months later showed normal finding. The development of GBS in our patient may be secondary to her anti-TNF-alpha treatment. At present, she remains off anti-TNF-alpha therapy.
    Full-text · Article · Apr 2009 · Clinical Rheumatology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectifs La polyarthrite rhumatoïde (PR) est une maladie auto-immune d’origine multifactorielle qui pose un problème socioéconomique important au Maroc. L’association de cette maladie avec les gènes HLA a été étudiée dans différents groupes ethniques. Notre étude s’est intéressée, pour la première fois au Maroc, à évaluer la distribution et l’implication des gènes HLA classe I et II chez des patients présentant une PR précoce. Méthodes Quarante-neuf patients atteints de PR précoce ont été comparés à des témoins sains appariés par âge, sexe et origine ethnique. Parmi ces patients, 34 étaient séropositifs (présence du facteur rhumatoïde). Le typage HLA des patients et des témoins a été réalisé par microlymphocytotoxicité pour la classe I (A et B) et en biologie moléculaire (PCR-SSP) pour la classe II (DR et DQ). Résultats Nous avons observé, chez les patients séropositifs, une augmentation significative de la fréquence de l’antigène A24 (p = 0,03) et des allèles DRB1*04 (p = 0,004) et DQB*03 (p = 0,03) et une diminution significative de l’allèle DRB1*07 (p = 0,03). La fréquence des allèles DRB1*01, DRB1*10 et DRB1*14 était comparable chez les patients et les témoins. La fréquence des haplotypes DR4-DQ2 et DR4-DQ4 était augmentée, alors que celle des haplotypes DR7-DQ2 et DR13-DQ6 était diminuée chez les patients. Conclusions Notre étude montre que l’allèle DRB1*04 prédispose à la PR alors que l’allèle DRB1*07 semble protecteur chez les patients marocains. Nos résultats suggèrent également le rôle de certains haplotypes DR-DQ dans la prédisposition ou la protection vis-à-vis de la maladie.
    Full-text · Article · Oct 2008 · Revue du Rhumatisme
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Rheumatoid arthritis (RA) is an autoimmune multifactorial disease which has a great socio-economic impact in Morocco. The association of HLA genes with RA was studied in various ethnic groups but not in the Moroccan population. Our study focused on evaluating the distribution of class I and class II HLA genes among Moroccan patients presenting early signs of RA. Forty nine patients diagnosed with early RA were compared to a group of healthy controls matched by age, sex, and ethnic origin. Among the patient group, 34 were seropositive (presence of the rheumatoid factor). HLA typing of the patients and the controls was performed using microlymphocytotoxicity for class I (A and B) and PCR-SSP for class II (DR and DQ). We found a significant increase of the frequency of the HLA-A24 antigen (p=0.03), the DRB1*04 (p=0.004) and DQB1*03 (p=0.03) alleles and a significant decrease of the DRB1*07 allele (p=0.03) in seropositive patients. The analysis of the frequency of the DRB1*01, DRB1*10, and DRB1*14 alleles did not show any difference between the RA patients and the controls. The frequency of DR4-DQ2 and DR4-DQ4 haplotypes was increased in the patients compared to the controls while that of DR7-DQ2 and DR13-DQ6 was decreased. Our study suggests that DRB1*04 predisposes to RA while DRB1*07 seems protective for the Moroccan patients population. In addition we show the influence of some haplotypes DR-DQ in the susceptibility and protection against the disease.
    Full-text · Article · Oct 2008 · Joint, bone, spine: revue du rhumatisme

Publication Stats

372 Citations
93.70 Total Impact Points

Institutions

  • 2012
    • University Mohammed V Agdal
      Rabat, Rabat-Salé-Zemmour-Zaër, Morocco
  • 2008-2011
    • Centre Hospitalier Universaitaire IBN Sina de Rabat
      Rabat, Rabat-Salé-Zemmour-Zaër, Morocco
  • 2005
    • Ibn Sina Hospital Dhanmondi
      Baghdād, Mayorality of Baghdad, Iraq